Clinical Trial Update: Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating substitution of atazanavir (with or without ritonavir boosting) for ritonavir-boosted protease inhibitors in people with HIV a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperlipidemia

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Stanford University | Conditions: Hyperlipidemia, HIV Infections | Phase 3 | Status: COMPLETED